Literature DB >> 23426945

The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis.

Zhiying Zou1, David R Enis, Hung Bui, Eugene Khandros, Vinayak Kumar, Zoltan Jakus, Christopher Thom, Yiqing Yang, Veerpal Dhillon, Mei Chen, Minmin Lu, Mitchell J Weiss, Mark L Kahn.   

Abstract

The secreted protein CCBE1 is required for lymphatic vessel growth in fish and mice, and mutations in the CCBE1 gene cause Hennekam syndrome, a primary human lymphedema. Here we show that loss of CCBE1 also confers severe anemia in midgestation mouse embryos due to defective definitive erythropoiesis. Fetal liver erythroid precursors of Ccbe1 null mice exhibit reduced proliferation and increased apoptosis. Colony-forming assays and hematopoietic reconstitution studies suggest that CCBE1 promotes fetal liver erythropoiesis cell nonautonomously. Consistent with these findings, Ccbe1(lacZ) reporter expression is not detected in hematopoietic cells and conditional deletion of Ccbe1 in hematopoietic cells does not confer anemia. The expression of the erythropoietic factors erythropoietin and stem cell factor is preserved in CCBE1 null embryos, but erythroblastic island (EBI) formation is reduced due to abnormal macrophage function. In contrast to the profound effects on fetal liver erythropoiesis, postnatal deletion of Ccbe1 does not confer anemia, even under conditions of erythropoietic stress, and EBI formation is normal in the bone marrow of adult CCBE1 knockout mice. Our findings reveal that CCBE1 plays an essential role in regulating the fetal liver erythropoietic environment and suggest that EBI formation is regulated differently in the fetal liver and bone marrow.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426945      PMCID: PMC3655737          DOI: 10.1182/blood-2012-10-462689

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

Review 1.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

2.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.

Authors:  A Irrthum; M J Karkkainen; K Devriendt; K Alitalo; M Vikkula
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

3.  Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver.

Authors:  K Kawane; H Fukuyama; G Kondoh; J Takeda; Y Ohsawa; Y Uchiyama; S Nagata
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

4.  c-Maf plays a crucial role for the definitive erythropoiesis that accompanies erythroblastic island formation in the fetal liver.

Authors:  Manabu Kusakabe; Kazuteru Hasegawa; Michito Hamada; Megumi Nakamura; Takayuki Ohsumi; Hirona Suzuki; Mai Thi Nhu Tran; Takashi Kudo; Kazuhiko Uchida; Haruhiko Ninomiya; Shigeru Chiba; Satoru Takahashi
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

Review 5.  Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: a review.

Authors:  Inge D C Van Balkom; Mariel Alders; Judith Allanson; Carlo Bellini; Ulrich Frank; Greetje De Jong; Ingeborg Kolbe; Didier Lacombe; Stan Rockson; Peter Rowe; Frits Wijburg; Raoul C M Hennekam
Journal:  Am J Med Genet       Date:  2002-11-01

6.  VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.

Authors:  Luqing Zhang; Fei Zhou; Wencan Han; Bin Shen; Jincai Luo; Masabumi Shibuya; Yulong He
Journal:  Cell Res       Date:  2010-08-10       Impact factor: 25.617

7.  Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis.

Authors:  Jian Xu; Zhen Shao; Kimberly Glass; Daniel E Bauer; Luca Pinello; Ben Van Handel; Serena Hou; John A Stamatoyannopoulos; Hanna K A Mikkola; Guo-Cheng Yuan; Stuart H Orkin
Journal:  Dev Cell       Date:  2012-10-04       Impact factor: 12.270

8.  Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Authors:  Marika J Karkkainen; Paula Haiko; Kirsi Sainio; Juha Partanen; Jussi Taipale; Tatiana V Petrova; Michael Jeltsch; David G Jackson; Marja Talikka; Heikki Rauvala; Christer Betsholtz; Kari Alitalo
Journal:  Nat Immunol       Date:  2003-11-23       Impact factor: 25.606

9.  Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis.

Authors:  Paul D Kingsley; Jeffrey Malik; Katherine A Fantauzzo; James Palis
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Endothelial and perivascular cells maintain haematopoietic stem cells.

Authors:  Lei Ding; Thomas L Saunders; Grigori Enikolopov; Sean J Morrison
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more
  17 in total

1.  Getting to the Ncor of HSC emergence.

Authors:  Teresa V Bowman
Journal:  Blood       Date:  2014-09-04       Impact factor: 22.113

2.  Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC.

Authors:  Lillian Lim; Hung Bui; Olivia Farrelly; Jisheng Yang; Li Li; David Enis; Wanshu Ma; Mei Chen; Guillermo Oliver; John D Welsh; Mark L Kahn
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

3.  Cell Adhesion Mediated by VCAM-ITGα9 Interactions Enables Lymphatic Development.

Authors:  Yiqing Yang; David Enis; Hui Zheng; Stephanie Chia; Jisheng Yang; Mei Chen; Veerpal Dhillon; Thalia Papayannapoulou; Mark L Kahn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

4.  Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.

Authors:  Hung M Bui; David Enis; Marius R Robciuc; Harri J Nurmi; Jennifer Cohen; Mei Chen; Yiqing Yang; Veerpal Dhillon; Kathy Johnson; Hong Zhang; Robert Kirkpatrick; Elizabeth Traxler; Andrey Anisimov; Kari Alitalo; Mark L Kahn
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

5.  Vascular endothelial growth factor c regulates hematopoietic stem cell fate in the dorsal aorta.

Authors:  Rebecca K Schiavo; Owen J Tamplin
Journal:  Development       Date:  2022-01-18       Impact factor: 6.868

Review 6.  Mouse Models of Erythropoiesis and Associated Diseases.

Authors:  Matthew P Parker; Kenneth R Peterson
Journal:  Methods Mol Biol       Date:  2018

7.  Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Authors:  A Mendola; M J Schlögel; A Ghalamkarpour; A Irrthum; H L Nguyen; E Fastré; A Bygum; C van der Vleuten; C Fagerberg; E Baselga; I Quere; J B Mulliken; L M Boon; P Brouillard; M Vikkula
Journal:  Mol Syndromol       Date:  2013-08-21

8.  VEGF-C protects the integrity of the bone marrow perivascular niche in mice.

Authors:  Shentong Fang; Shuo Chen; Harri Nurmi; Veli-Matti Leppänen; Michael Jeltsch; David Scadden; Lev Silberstein; Hanna Mikkola; Kari Alitalo
Journal:  Blood       Date:  2020-10-15       Impact factor: 22.113

9.  Prostaglandin E2 Enhances Aged Hematopoietic Stem Cell Function.

Authors:  Andrea M Patterson; P Artur Plett; Carol H Sampson; Edward Simpson; Yunlong Liu; Louis M Pelus; Christie M Orschell
Journal:  Stem Cell Rev Rep       Date:  2021-05-11       Impact factor: 5.739

10.  CCBE1 mutation in two siblings, one manifesting lymphedema-cholestasis syndrome, and the other, fetal hydrops.

Authors:  Sohela Shah; Laura K Conlin; Luis Gomez; Øystein Aagenaes; Kristin Eiklid; A S Knisely; Michael T Mennuti; Randolph P Matthews; Nancy B Spinner; Laura N Bull
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.